Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? - Wikidata - awgldk - TriplyDB

Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?

Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?

http://www.wikidata.org/entity/Q36404577

about

Neural correlates of cognitive improvements following cognitive remediation in schizophrenia: a systematic review of randomized trials A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia The Efficacy of Non-Pharmacological Interventions on Brain-Derived Neurotrophic Factor in Schizophrenia: A Systematic Review and Meta-Analysis Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics Do "Brain-Training" Programs Work?A longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophrenia Neuroscience-informed Auditory Training in Schizophrenia: A Final Report of the Effects on Cognition and Serum Brain-Derived Neurotrophic Factor.Brain plasticity-based therapeutics Computer-assisted cognitive remediation for schizophrenia: a randomized single-blind pilot study.Manipulation of BDNF signaling modifies the experience-dependent plasticity induced by pure tone exposure during the critical period in the primary auditory cortex.Cognitive training for impaired neural systems in neuropsychiatric illness When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia Brain-derived neurotrophic factor (BDNF) Val(66)Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia.DNA methylation of BDNF as a biomarker of early-life adversity Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder.Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia: A systematic review Relationship between brain-derived neurotrophic factor gene C270T polymorphisms and the psychotic symptoms and cognitive functioning of patients with schizophrenia Neurobiology of cognitive remediation therapy for schizophrenia: a systematic review Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis.New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases.Prefrontal cortical changes following cognitive training in patients with chronic schizophrenia: effects of practice, generalization, and specificity.Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia.Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression Compensatory cognitive training for psychosis: who benefits? Who stays in treatment?A pilot study on the effect of cognitive training on BDNF serum levels in individuals with Parkinson's disease.Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome Intensive cognitive training in schizophrenia enhances working memory and associated prefrontal cortical efficiency in a manner that drives long-term functional gains.Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: theoretical considerations and current state of evidence.A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays.BDNF-TrkB signaling and neuroprotection in schizophrenia A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia.Compensatory cognitive training for psychosis: effects in a randomized controlled trial.Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia.Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development.Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.

P2860

Q26753204-70B4BE50-BF5E-475F-9310-BAB9C67FE518 Q26786354-BD6A120D-9363-46BA-BF4C-1A169F97AC9F Q26864324-A467668D-59E7-4ED2-9B75-E7AE90C6D040 Q27320479-6FA8FED7-2724-42A0-B6C7-BFE914D38C05 Q28066603-6AA4B44B-BDB0-411D-B27E-37CB8A7847CE Q28068871-B27C3121-309C-46D1-9452-7E134DE681DB Q28279012-2270E5AB-F249-448D-ABA6-FC710FD42603 Q28539784-FE5FC412-23D0-4663-8DAE-1060573939CC Q30362469-061C4940-42FF-4717-BC15-6D77ACB4551C Q30435021-CF8BA91D-594E-44FA-9E8F-20DDEE2E4E60 Q30451654-AE10EED4-0320-4FBB-9855-CF066454D7A2 Q30454448-E3DC33AF-EB2A-4B0E-A941-9730F6A481F0 Q30459618-885C346C-33F2-41C8-A624-A07602476258 Q30478986-4E6BC4BB-2EDC-4326-9217-B4DB084580BE Q30586016-672CDE25-DE78-4962-AE05-F6F65A9001E1 Q30653771-B445E31E-DF7B-4ACE-8FE0-57CCB962B659 Q33847022-7CF9141B-52C2-41D4-8C2D-FA8944C87F66 Q34126472-130FCB95-5A09-469B-90F3-1D7322A5A313 Q34132832-98DA0F8B-CD2B-4866-B620-F5CE8C9EC433 Q34347464-82C74281-4C3E-4C01-8D5A-D90A8FD1AEB5 Q34347578-81EA1771-C1CB-422A-BD24-9D0ADC36DD6D Q34436237-B71375F9-B0F4-40A9-BE31-43FBDF923D63 Q34548501-3A8A8F4B-E5A8-4CF9-9EDA-DF641CA7261B Q34567939-E4868EA7-42AC-48C7-BEDE-9CB97759DE08 Q34661681-E480871D-9455-4647-8A74-2AF365A8846C Q34830625-EC036081-7EB1-4EB6-8EB9-AF4945FBF4CC Q35162627-F170AB04-24C6-44F0-8B0F-0F7B63558816 Q35176769-56020431-B304-4E22-97FA-DC63B076F9C5 Q35179790-45E92E14-EF16-41F3-94A7-B4D3CF0B1EC2 Q35284133-70855FC6-D732-4A5F-B382-4BCC7454D1C2 Q35841673-5C847B71-4555-4E4A-824C-4269CD04B667 Q36169003-42B553AF-E103-4594-9D07-A2014B94FD72 Q36361793-1F0A5720-F4A7-47B6-BFD6-79658D5E4AA4 Q36589545-8E991FBE-4F7F-4D5E-8FB5-A90CA1CD86D1 Q36600804-C38EF2D1-6D50-42D4-BAE8-8AB79F8ED904 Q36672355-4F81F9FF-B5BB-4857-A3F5-A76BF18CFA50 Q36900676-7FFB6678-87A4-4F27-89C6-85EF49EDEC26 Q36930839-4C20DE79-8142-4251-BBA1-E37DA706D558 Q36935148-5BC6A865-70C5-4472-B34B-2FA17454D6A4 Q37090593-F7C31F25-4EF2-4298-BE20-A19A029D19F1

P2860

Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?

http://www.wikidata.org/entity/Q36404577

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Is serum brain-derived neurotr ...... enhancement in schizophrenia?

@ast

Is serum brain-derived neurotr ...... enhancement in schizophrenia?

@en

type

label

Is serum brain-derived neurotr ...... enhancement in schizophrenia?

@ast

Is serum brain-derived neurotr ...... enhancement in schizophrenia?

@en

prefLabel

Is serum brain-derived neurotr ...... enhancement in schizophrenia?

@ast

Is serum brain-derived neurotr ...... enhancement in schizophrenia?

@en

P1433

Q36404577-1664FD3A-4D51-4D15-B766-A8971CCE7F1E

P1476

Q36404577-AA5FE03C-A357-4FA6-809F-9C6EB3463F7A

P2093

Q36404577-152456F1-F8E7-4264-A205-A247BB87DF3F

Q36404577-36CE5B88-BB5A-4509-825C-67009B7F98FC

Q36404577-7E34969C-C34C-406C-AAD3-75D36EE61883

Q36404577-9ABE662A-7B62-4696-B6D6-F0C757627097

Q36404577-C7A81C81-ED49-4D59-90B5-61E54CD16412

P2860

Q36404577-0615E555-ED54-4A90-86D8-D56BA4037A85

Q36404577-0738152F-96A1-43DD-B44C-7D1339561B64

Q36404577-08776678-2502-41D8-B27B-4163C4E834D7

Q36404577-0ACD4804-A353-41FE-A858-86AB5962609B

Q36404577-0E97E7AC-0BA9-4DED-8AD0-FA966CFF5C52

Q36404577-218B4962-D706-4FB3-B0F9-9C8B96D6B4D1

Q36404577-25B60A45-C727-4244-9947-10AF8D63A825

Q36404577-274C34B0-FD65-45CE-A30C-4EF2D6B2CAFF

Q36404577-291E7E54-5C13-4573-8FD1-C0A9F534EB49

Q36404577-2B6A4893-D80F-4B17-9342-9AA18952139E

P304

Q36404577-585AC7E9-2FF3-4CAF-94D6-F3545B72A894

P31

Q36404577-A25E002A-B728-4CC6-9655-4CEA8D5B2FD7

P356

Q36404577-480F0D96-8AB6-45FD-B0D5-4E556BCC8ADF

P407

Q36404577-452AD0DB-D4EE-4C66-AD64-51A0FC611FA8

P433

Q36404577-5390C1D8-127D-4304-BE0D-16996D1390B4

P478

Q36404577-A8CE9728-B5A5-4CAA-9FB0-3A67FBBFE6CB

P50

Q36404577-0904AC19-5DF2-48BF-891B-11AB07CC6A71

P577

Q36404577-A3F27A7B-53D4-40BB-85CD-F0E970A42790

P698

Q36404577-AD7F92F8-7E63-4C2D-8F6A-D186A9EA3276

P921

Q36404577-3D6F5303-B377-4491-8667-F610AB8D8B85

Q36404577-468F82AD-7ECF-4C62-8B15-4EB39206D55E

P932

Q36404577-97BB567B-6F71-487A-8D84-888C4DC3BE83

P356

J.BIOPSYCH.2009.02.017

P1433

Biological Psychiatry

P1476

Is serum brain-derived neurotr ...... enhancement in schizophrenia?

@en

P2093

Christine Holland

http://www.w3.org/2001/XMLSchema#string

Melissa Fisher

http://www.w3.org/2001/XMLSchema#string

Sophia Vinogradov

http://www.w3.org/2001/XMLSchema#string

Synthia H Mellon

http://www.w3.org/2001/XMLSchema#string

Wendy Shelly

http://www.w3.org/2001/XMLSchema#string

P2860

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites

Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia.

Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective.

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.

Neurotrophins and schizophrenia.

The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia.

Decreased neurotrophic response to birth hypoxia in the etiology of schizophrenia.

Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients.

P304

549-553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2009.02.017

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Owen M. Wolkowitz

P577

2009-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19368899

http://www.w3.org/2001/XMLSchema#string

P921

P932

4691262

http://www.w3.org/2001/XMLSchema#string